{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:44:33Z","timestamp":1784130273481,"version":"3.55.0"},"reference-count":16,"publisher":"American Society for Microbiology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1128\/cvi.00504-15","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T13:54:48Z","timestamp":1448373288000},"page":"1296-1297","source":"Crossref","is-referenced-by-count":2,"title":["Reply to \u201cImmunosuppression in a Comparative Study of Feline Leukemia Virus Vaccines\u201d"],"prefix":"10.1128","volume":"22","author":[{"given":"M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Carritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jayappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"key20180919073818_B1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1128\/CVI.00034-15","article-title":"Comparative efficacy of feline leukemia virus (FeLV) inactivated whole-virus vaccine and canarypox virus-vectored vaccine during virulent FeLV challenge and immunosuppression","volume":"22","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"key20180919073818_B2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1128\/JVI.67.4.2370-2375.1993","article-title":"Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL","volume":"67","year":"1993","journal-title":"J Virol"},{"key":"key20180919073818_B3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/vr.153.5.141","article-title":"Efficacy of a canarypox virus-vectored vaccine against feline leukaemia","volume":"153","year":"2003","journal-title":"Vet Rec"},{"key":"key20180919073818_B4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.vaccine.2005.09.010","article-title":"Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays","volume":"24","year":"2006","journal-title":"Vaccine"},{"key":"key20180919073818_B5","first-page":"258","article-title":"Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously","volume":"5","year":"2004","journal-title":"Vet Ther"},{"key":"key20180919073818_B6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2460\/javma.228.5.726","article-title":"Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine","volume":"228","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"key20180919073818_B7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/JVI.02234-13","article-title":"A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine","volume":"88","year":"2014","journal-title":"J Virol"},{"key":"key20180919073818_B8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.vetimm.2009.10.017","article-title":"Feline leukemia virus immunity induced by whole inactivated virus vaccination","volume":"134","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"key20180919073818_B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1939-1676.1993.tb03166.x","article-title":"Immunogenicity and efficacy of a commercial feline leukemia virus vaccine","volume":"7","year":"1993","journal-title":"J Vet Intern Med"},{"key":"key20180919073818_B10","first-page":"E1","article-title":"Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine","volume":"11","year":"2010","journal-title":"Vet Ther"},{"key":"key20180919073818_B11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jfms.2008.03.002","article-title":"American Association of Feline Practitioners' feline retrovirus management guidelines","volume":"10","year":"2008","journal-title":"J Feline Med Surg"},{"key":"key20180919073818_B12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2460\/javma.2005.226.548","article-title":"Assessment of stress levels among cats in four animal shelters","volume":"226","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"key20180919073818_B13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1939-1676.1996.tb02043.x","article-title":"Urine cortisol:creatinine ratio in healthy and sick cats","volume":"10","year":"1996","journal-title":"J Vet Intern Med"},{"key":"key20180919073818_B14","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jfms.2011.07.009","article-title":"Detection of protective antibody titers against feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus in shelter cats using a point-of-care ELISA","volume":"13","year":"2011","journal-title":"J Feline Med Surg"},{"key":"key20180919073818_B15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jfms.2009.05.023","article-title":"Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter","volume":"11","year":"2009","journal-title":"J Feline Med Surg"},{"key":"key20180919073818_B16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2460\/javma.1991.199.10.1402","article-title":"United States Department of Agriculture licensing requirements for feline leukemia virus vaccines","volume":"199","year":"1991","journal-title":"J Am Vet Med Assoc"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00504-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:10:06Z","timestamp":1718212206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00504-15"}},"subtitle":[],"editor":[{"given":"M. F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,11,24]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1128\/CVI.00504-15"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00504-15","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}